Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FloSeal Matrix in Endoscopic Vein Harvest
NCT00742313Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jun 2009
- Primary completion
- Sep 2012
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gelatin + thrombin in hemorrhage, sponsored by Duke University. Primary endpoint: Number of Participants With Decreased Bleeding at 14 days. Started Jun 2009; status: terminated.
02
Drugs
gelatin + thrombin
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT00742313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742313.